Stock Fundamentals

Company Information

Company Name
Novocure Ltd
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: JE00BYSS4X48
CIK: 0001645113
CUSIP: G6674U108
Currency: USD
Full Time Employees: 1,605
Phone: 44 15 3475 6700
Fiscal Year End: December
IPO Date: Oct 02, 2015
Description:

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Address:

Neuhofstrasse 21, Baar, Switzerland, 6340

Directors & Officers

Name Title Year Born
Mr. William F. Doyle Executive Chairman 1962
Mr. Frank Leonard CEO & Director NA
Mr. Christoph Brackmann Chief Financial Officer 1974
Mr. Michael Puri Chief Human Resources Officer 1969
Dr. Uri Weinberg M.D., Ph.D. Chief Innovation Officer & Chief Medical Officer 1978
Mr. Mukund Paravasthu Chief Operating Officer 1970
Mr. Adam Daney Head of Investor Relations NA
Mr. Barak Ben-Arye General Counsel 1977

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 05, 2026 Mukund Paravasthu N/A Sale 43.25K $13.77 $595.50K
Mar 04, 2026 Christoph Brackmann N/A Sale 6.41K $13.31 $85.34K
Mar 04, 2026 Frank X Leonard N/A Sale 5.61K $13.31 $74.63K
Mar 04, 2026 Michal Nath Puri N/A Sale 1.10K $13.31 $14.64K
Mar 04, 2026 Mukund Paravasthu N/A Sale 5.38K $13.31 $71.57K
Mar 04, 2026 Uri Weinberg N/A Sale 6.41K $13.31 $85.34K
Mar 03, 2026 William F Doyle N/A Sale 71.89K $12.98 $933.09K
Sep 05, 2025 Ashley Cordova N/A Purchase 81.55K $12.22 $996.54K
Jul 29, 2025 Christoph Brackmann N/A Purchase 20.00K $11.59 $231.80K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 17.07M Mar 31, 2026 14.74% $0.01 1.62%
BlackRock Inc 13.19M Mar 31, 2026 11.39% $0.00 -2.57%
Vanguard Group Inc 10.96M Dec 31, 2025 9.46% $0.00 4.80%
Soleus Capital Management, L.P. 10.49M Mar 31, 2026 9.06% $4.63 23.00%
Vanguard Portfolio Management, LLC 6.25M Mar 31, 2026 5.40% $0.00 0.00%
Vanguard Capital Management, LLC 4.68M Mar 31, 2026 4.04% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 4.54M Mar 31, 2026 3.92% $0.00 -10.42%
Wells Fargo & Co 2.95M Mar 31, 2026 2.55% $0.01 1,995.86%
State Street Corp 2.56M Mar 31, 2026 2.21% $0.00 -0.60%
Geode Capital Management, LLC 2.51M Mar 31, 2026 2.17% $0.00 1.42%
Quantinno Capital Management LP 2.49M Mar 31, 2026 2.15% $0.05 23.73%
Renaissance Technologies Corp 1.55M Mar 31, 2026 1.34% $0.03 11.80%
Point72 Asset Management, L.P. 1.36M Mar 31, 2026 1.18% $0.02 51.18%
Jacobs Levy Equity Management, Inc. 1.33M Mar 31, 2026 1.15% $0.06 8.80%
Palo Alto Investors, LLC 1.28M Mar 31, 2026 1.11% $2.13 -1.43%
SG Americas Securities, LLC 1.25M Mar 31, 2026 1.08% $0.01 346.74%
Baillie Gifford & Co Limited. 1.07M Mar 31, 2026 0.93% $0.01 -4.43%
Schroder Investment Management Group 1.02M Mar 31, 2026 0.88% $0.01 0.00%
Nuveen, LLC 982.35K Mar 31, 2026 0.85% $0.00 -22.85%
CAM Group Holding A/S 971.78K Mar 31, 2026 0.84% $0.23 0.00%

Shares Statistics

Shares Outstanding: 115.82M
Shares Float: 95.22M
% Insiders: 1,001.30%
% Institutions: 8,835.60%
Short % Float: 11.29%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 8.15M 7.04% ▲ 0.07% Apr 30, 2026
2 Fidelity Growth Company Fund 5.85M 5.05% ▲ 5.75% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 3.42M 2.95% ▲ 1.85% Apr 30, 2026
4 Vanguard Small Cap Index 2.49M 2.15% ▼ 0.33% Apr 30, 2026
5 iShares Russell 2000 ETF 2.43M 2.09% ▲ 0.93% May 29, 2026
6 Fidelity Growth Company K6 1.73M 1.50% ▼ 0.32% Apr 30, 2026
7 Fidelity Series Growth Company 1.55M 1.33% ▼ 5.73% Apr 30, 2026
8 Vanguard Small Cap Growth Index Inv 1.39M 1.20% ▼ 0.08% Apr 30, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 1.15M 0.99% ▲ 1.23% Apr 30, 2026
10 International Biotechnology Ord 1.02M 0.88% ▲ 0.00% Feb 28, 2026

Valuation Metrics

Enterprise Value: $1.80B
Trailing P/E: 0.00
Forward P/E: 909.09

Financial Highlights

Market Cap: $2.00B
EBITDA: $-166.22M
PEG Ratio: $-0.47
Book Value: $2.86
Earnings/Share: $-1.52
Profit Margin: -25.66%
Operating Margin: -38.74%
ROA (TTM): -11.06%
ROE (TTM): -49.97%
Revenue (TTM): $674.41M
Revenue/Share (TTM): $6.00
Earnings Growth (YOY): -6.00%
Revenue Growth (YOY): 12.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.90x 0.61x 0.58x -9.03x -1.74x
2024-12-31 1.46x 1.84x 0.71x -14.62x -6.05x
2023-12-31 5.78x 1.80x 0.68x -47.47x -3.68x
2022-12-31 7.00x 1.45x 0.63x -26.85x -8.10x
2021-12-31 7.53x 1.54x 0.64x -12.89x -18.55x
2020-12-31 8.80x 0.92x 0.55x 1.68x 9.73x
2019-12-31 5.10x 0.86x 0.55x -0.07x 24.79x
2018-12-31 4.98x 1.33x 0.67x -2.50x -6.05x
2017-12-31 4.88x 1.72x 0.57x -3.83x -6.17x
2016-12-31 7.10x 1.35x 0.50x -19.42x -1.76x
2015-12-31 10.27x 0.19x 0.18x -43.82x -0.46x
2014-12-31 6.33x 0.01x 0.17x -438.01x -0.01x
2013-12-31 11.76x 0.00x 0.09x -5.09x -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVCR.US!